IPF therapy is in Boehringer's radar
In addition to €45 million in upfront and near-term payments, Bridge Biotherapeutics could end up netting more than €1.1 billion in total if it meets all of its milestones.
For more info:
https://www.fiercebiotech.com/biotech/looking-for-ofev-follow-up-boehringer-picks-up-bridge-biotherapeutics-ipf-med-for-50m?mkt_tok=eyJpIjoiTnpNeE9XWTVZVGhoWkdVNCIsInQiOiJ1dXg2XC9QWnQ2enhSMUdpbUlZM01IM29PN0tpczF1STVhWEtidFE3VGV3TkRzdkdyTXBQa2RSaWFtcTNMald5cG1maHNIeTNvMXp0eFpGRXdsOE5oTEpiNlg5RU5JYjB4dyttM2VBSnlsY0VubTF6Ung4RElLQWtkcDN2Mko0ajEifQ%3D%3D&mrkid=748367
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $5.858K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 25599399 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 6805828 | 16 |
View Market Depth
| Last trade - 16.15pm 24/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |